Prevalent Cardiovascular Disease and Atrial Fibrillation in Relation to Cerebral Small Vessel Disease Burden

Oluchi Ekenze1,2, Adlin Pinheiro1,3, Alexa S Beiser1,2,3

  • 1NHLBI's Framingham Heart Study, Framingham, MA 01702, USA.

Brain Sciences
|August 28, 2025
PubMed

Insights

Cardiovascular disease (CVD) and atrial fibrillation (AF) are linked to cerebral small vessel disease (CSVD). This association was observed, particularly with cerebral microbleeds, highlighting a connection between heart conditions and brain health.

Area of Science:

  • Neurology and Cardiology
  • Neuroimaging and Cardiovascular Health

Background:

  • Cardiovascular disease (CVD) is a significant risk factor for stroke and dementia.
  • Shared risk factors between CVD, stroke, and dementia may involve cerebral small vessel disease (CSVD).
  • Atrial fibrillation (AF) is a common cardiac arrhythmia often co-occurring with CVD.

Purpose of the Study:

  • To investigate the association between prevalent cardiovascular disease (CVD) and atrial fibrillation (AF).
  • To determine the relationship between CVD and AF with the burden of cerebral small vessel disease (CSVD).
  • To explore specific CSVD markers associated with CVD and AF.

Main Methods:

  • Assessed composite CVD (coronary heart disease, heart failure) and AF in 3413 participants.
  • Utilized a multi-marker CSVD score (0-5) based on cerebral microbleeds, perivascular spaces, white matter hyperintensity, siderosis, and infarcts.
  • Employed logistic regression analyses, adjusted for demographics and vascular risk factors, to relate CVD/AF to CSVD markers.

Main Results:

  • Prevalent CVD or AF was present in 11% of participants; 8% had CVD, and 4% had AF.
  • 23% of participants showed one CSVD marker, and 9% had two or more.
  • Composite CVD and AF were associated with one CSVD marker (OR: 1.38, 95% CI: 1.05-1.84); cerebral microbleeds (CMBs) showed the strongest association with CVD components, especially heart failure.

Conclusions:

  • Prevalent cardiovascular disease, including atrial fibrillation, is associated with the presence of cerebral small vessel disease.
  • Cerebral microbleeds are specifically linked to components of CVD and AF.
  • Findings suggest a connection between cardiovascular health and underlying cerebral small vessel disease.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
21
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54